A possible explanation is differences in first-pass metabolism among individual ... the rectal suppositories resulted in a mean 16% lower bioavailability compared with the 50-mg oral syrup.

Raanana, Israel, Jan. 30, 2025 (GLOBE NEWSWIRE) -- (Nasdaq: PLRZ) (the “Company” or “Polyrizon”), a development-stage biotech company specializing in the development of innovative intranasal ...